These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38500373)

  • 1. Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction.
    Suda M; Paul KH; Tripathi U; Minamino T; Tchkonia T; Kirkland JL
    Endocr Rev; 2024 Mar; ():. PubMed ID: 38500373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senolytic drugs: from discovery to translation.
    Kirkland JL; Tchkonia T
    J Intern Med; 2020 Nov; 288(5):518-536. PubMed ID: 32686219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials.
    Romashkan S; Chang H; Hadley EC
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1144-1152. PubMed ID: 33528569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
    Khalil R; Diab-Assaf M; Lemaitre JM
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senopathies-Diseases Associated with Cellular Senescence.
    Lushchak O; Schosserer M; Grillari J
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescent Cells: A Therapeutic Target in Cardiovascular Diseases.
    Suda M; Paul KH; Minamino T; Miller JD; Lerman A; Ellison-Hughes GM; Tchkonia T; Kirkland JL
    Cells; 2023 May; 12(9):. PubMed ID: 37174697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senescence and the SASP: many therapeutic avenues.
    Birch J; Gil J
    Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications.
    Basisty N; Kale A; Patel S; Campisi J; Schilling B
    Expert Rev Proteomics; 2020 Apr; 17(4):297-308. PubMed ID: 32425074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
    Murakami T; Inagaki N; Kondoh H
    Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
    Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
    EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cellular senescence in ageing and endocrine disease.
    Khosla S; Farr JN; Tchkonia T; Kirkland JL
    Nat Rev Endocrinol; 2020 May; 16(5):263-275. PubMed ID: 32161396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Senescence: A Translational Perspective.
    Kirkland JL; Tchkonia T
    EBioMedicine; 2017 Jul; 21():21-28. PubMed ID: 28416161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Clinical Implications of Senotherapies for Cardiovascular Disease.
    Suda M; Katsuumi G; Tchkonia T; Kirkland JL; Minamino T
    Circ J; 2024 Feb; 88(3):277-284. PubMed ID: 37880106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular senescence and senolytics: the path to the clinic.
    Chaib S; Tchkonia T; Kirkland JL
    Nat Med; 2022 Aug; 28(8):1556-1568. PubMed ID: 35953721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction.
    Nehlin JO
    Adv Protein Chem Struct Biol; 2023; 136():217-247. PubMed ID: 37437979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms.
    Tchkonia T; Palmer AK; Kirkland JL
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1481-e1487. PubMed ID: 33155651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, Senescence, and Senolytics.
    Chaib S; Tchkonia T; Kirkland JL
    Handb Exp Pharmacol; 2022; 274():165-180. PubMed ID: 34697668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.
    Kang C
    Mol Cells; 2019 Dec; 42(12):821-827. PubMed ID: 31838837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
    Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.